Jun 2026 (Q2 FY26) — Aug 6, 2026
Delcath Systems Q2 FY26 — Strong Revenue Growth and Raised Full-Year Outlook
Read the full callDelcath Systems (DCTH) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Delcath Systems earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 29.1 | +20.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 8.2 | −2.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 2.7 | −1.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$14.81 +0.61% · +$0.09
Performance +30.3% 1Y
1Y: $11.37 on 14 Oct 2025 → $14.81. High $17.36 (13 Aug 2026), low $8.19 (20 Nov 2025).
- Previous close
- $14.72
- 52-week range
- $8.19 – $17.36
- One year
- +30.83%
Overview
- Symbol
- DCTH
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Delcath Systems earnings calls (DCTH)
Financials
What the filings say
Net profit, year on year: −1% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 11 | 15 | 20 | 24 | 21 | 21 | 25 | 29 |
| Operating profit | -1 | 3 | 1 | 3 | -0 | -2 | -2 | 2 |
| Operating margin | −11.2% | 20.1% | 3.3% | 10.7% | −1.9% | −10.5% | −6.5% | 8.2% |
| Profit before tax | 2 | -3 | 1 | 3 | 0 | -1 | -1 | 3 |
| Tax rate | 0.0% | 0.0% | 15.4% | 15.8% | −121.3% | −42.1% | −17.8% | 15.5% |
| Net profit | 2 | -3 | 1 | 3 | 1 | -2 | -1 | 3 |
| EPS ($ per share) | 0.06 | — | 0.03 | 0.08 | 0.02 | — | -0.03 | 0.07 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -344 | -371 | -395 | -421 | -457 | -505 | -532 | -529 |
| Total liabilities | 22 | 21 | 13 | 21 | 24 | 23 | 8 | 12 |
| Fixed assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Total assets | 7 | 14 | 35 | 33 | 18 | 39 | 77 | 124 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -15 | -24 | -23 | -23 | -25 | -31 | -19 | 23 |
| Cash from investing | -0 | -0 | -1 | -0 | -0 | -20 | -1 | -27 |
| Cash from financing | 13 | 30 | 42 | 21 | 10 | 52 | 39 | 15 |
| Net cash flow | -2 | 7 | 19 | -2 | -15 | 1 | 20 | 11 |
| Capital expenditure | -0 | -0 | -1 | -0 | -0 | -0 | -1 | -2 |
| Free cash flow | -15 | -24 | -24 | -23 | -25 | -31 | -19 | 21 |
Insider filings
6 filings between Nov 11, 2025 and Oct 13, 2026.
Open market
decisions to buy or sellPurchases
$287.4K
4 purchases by 3 insiders
Sales
None
No insider sold shares.
Also filed: 1 conversion, 1 other.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| MICHEL GERARD J | $198.4K | — | Mar 2, 2026 |
| Pennell Sandra | $50.0K | — | Mar 6, 2026 |
| Sylvester John Richard | $39.0K | — | Nov 21, 2025 |
Latest filings (14)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Rosalind Advisors, Inc. Director | Conversion | 3,627 | $0 |
| Oct 13, 2026 | Rosalind Advisors, Inc. Director | Other | 27,502 | $0 |
| Mar 6, 2026 | Pennell Sandra Chief Financial Officer | Purchase | 5,533 | $50.0K |
| Mar 2, 2026 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Purchase | 11,200 | $100.3K |
| Nov 21, 2025 | Sylvester John Richard Director | Purchase | 4,386 | $39.0K |
| Nov 11, 2025 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Purchase | 11,500 | $98.0K |
| Jun 12, 2025 | Vukovic Vojo CHIEF MEDICAL OFFICER | Option exercise | 42,000 | $200.8K |
| May 5, 2025 | Aharon Gil Director | Option exercised | 400,000 | $4.00M |
| May 5, 2025 | SALAMON STEVEN A J Director | Option exercised | 400,000 | $4.00M |
| May 5, 2025 | Rosalind Advisors, Inc. Director | Option exercised | 400,000 | $4.00M |
| Dec 24, 2024 | SALAMON STEVEN A J Director | Conversion | 250,000 | $2.50M |
| Dec 24, 2024 | Aharon Gil Director | Conversion | 250,000 | $2.50M |
| Dec 24, 2024 | Rosalind Advisors, Inc. Director | Conversion | 250,000 | $2.50M |
| Oct 22, 2024 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Option exercise | 16,666 | $100.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for DELCATH SYSTEMS, INC.
Free account. Everything above stays public.
Write why you follow DELCATH SYSTEMS, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading